Literature DB >> 3993693

Neuropsychological deficits in early treated phenylketonuric children.

B F Pennington, W J van Doorninck, L L McCabe, E R McCabe.   

Abstract

In this preliminary study, six early treated children with phenylketonuria (PKU) were compared on the Halstead Neuropsychological Battery for Older Children with three groups of children with documented neurological disorders involving predominantly the left, the right, or bilateral dysfunction. The children with PKU had an overall level of neuropsychological impairment similar to that of the brain-damaged groups. The PKU group did not show a consistent pattern of lateralization, but there was some specificity to their deficits. The analyses showed that they were most similar to the right-hemisphere group. The children with PKU tended to show deficits consistently in two neuropsychological domains, conceptual and visuospatial skills, which would help explain their reported difficulty with mathematics. Further work is needed to test these results in a larger sample and to examine possible relationships with dietary compliance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3993693

Source DB:  PubMed          Journal:  Am J Ment Defic        ISSN: 0002-9351


  18 in total

1.  Preliminary neuropsychological test results.

Authors:  L M de Sonneville; E Schmidt; U Michel; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test.

Authors:  P Griffiths; R Campbell; P Robinson
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

3.  Wechsler subscale IQ and subtest profile in early treated phenylketonuria.

Authors:  P V Griffiths; C Demellweek; N Fay; P H Robinson; D C Davidson
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

4.  Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.

Authors:  M L Smith; W B Hanley; J T Clarke; P Klim; W Schoonheyt; V Austin; D C Lehotay
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

5.  The effects of diet discontinuation in children with phenylketonuria.

Authors:  F M Slijper; J Huisman; M M Hendrikx; A F Kalverboer; L vd Schot
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

6.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

7.  Contributions of Neuroscience to Our Understanding of Cognitive Development.

Authors:  Adele Diamond; Dima Amso
Journal:  Curr Dir Psychol Sci       Date:  2008-04

8.  Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.

Authors:  E Schmidt; P Burgard; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 9.  A prefrontal dysfunction model of early-treated phenylketonuria.

Authors:  M C Welsh
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 10.  Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  BMJ       Date:  1993-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.